• Home
  • Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context.

Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context.

Author List
Toth PP, Danese M, Villa G, Qian Y, Beaubrun A, Lira A, Jansen JP
Publication
Journal of medical economics
Publication ID (Profile URL)
https://researcherprofiles.org/profile/102292329
Publication Year
2017
PubMed ID
28097904
Publication Title
Toth PP, Danese M, Villa G, Qian Y, Beaubrun A, Lira A, Jansen JP. Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context. J Med Econ. 2017 Jun; 20(6):555-564.